Avid Bioservices Revenue vs. Current Valuation
| CDMO Stock | USD 12.23 0.08 0.65% |
Total Revenue | First Reported 1994-07-31 | Previous Quarter 40.2 M | Current Value 33.5 M | Quarterly Volatility 11.4 M |
For Avid Bioservices profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Avid Bioservices to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Avid Bioservices utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Avid Bioservices's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Avid Bioservices over time as well as its relative position and ranking within its peers.
Avid |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avid Bioservices. If investors know Avid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avid Bioservices listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.80) | Earnings Share (2.29) | Revenue Per Share 2.245 | Quarterly Revenue Growth 0.065 | Return On Assets (0.03) |
The market value of Avid Bioservices is measured differently than its book value, which is the value of Avid that is recorded on the company's balance sheet. Investors also form their own opinion of Avid Bioservices' value that differs from its market value or its book value, called intrinsic value, which is Avid Bioservices' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avid Bioservices' market value can be influenced by many factors that don't directly affect Avid Bioservices' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avid Bioservices' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avid Bioservices is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avid Bioservices' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Avid Bioservices Current Valuation vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Avid Bioservices's current stock value. Our valuation model uses many indicators to compare Avid Bioservices value to that of its competitors to determine the firm's financial worth. Avid Bioservices is rated third in revenue category among its peers. It is rated below average in current valuation category among its peers reporting about 6.82 of Current Valuation per Revenue. At this time, Avid Bioservices' Total Revenue is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Avid Bioservices' earnings, one of the primary drivers of an investment's value.Avid Revenue vs. Competition
Avid Bioservices is rated third in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 696.55 Million. Avid Bioservices totals roughly 139.91 Million in revenue claiming about 20% of equities under Health Care industry.
Avid Current Valuation vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Avid Bioservices |
| = | 139.91 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Avid Bioservices |
| = | 954.38 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Avid Current Valuation vs Competition
Avid Bioservices is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about 48.76 Billion. Avid Bioservices claims roughly 954.38 Million in current valuation contributing just under 2% to equities under Health Care industry.
Avid Bioservices Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Avid Bioservices, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Avid Bioservices will eventually generate negative long term returns. The profitability progress is the general direction of Avid Bioservices' change in net profit over the period of time. It can combine multiple indicators of Avid Bioservices, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | -18.7 M | -19.6 M | |
| Income Before Tax | -26.9 M | -28.3 M | |
| Total Other Income Expense Net | -8.2 M | -8.7 M | |
| Net Loss | -140.8 M | -133.7 M | |
| Income Tax Expense | 113.8 M | 119.5 M | |
| Net Loss | -140.8 M | -133.7 M | |
| Non Operating Income Net Other | 1.2 M | 1.2 M | |
| Net Income Applicable To Common Shares | 644 K | 676.2 K | |
| Interest Income | 152.9 K | 221.7 K | |
| Net Interest Income | -4.3 M | -4.1 M | |
| Change To Netincome | 11.3 M | 11.9 M | |
| Net Loss | (2.23) | (2.34) | |
| Income Quality | (0.08) | (0.07) | |
| Net Income Per E B T | 5.23 | 5.49 |
Avid Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Avid Bioservices. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Avid Bioservices position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Avid Bioservices' important profitability drivers and their relationship over time.
Use Avid Bioservices in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Avid Bioservices position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avid Bioservices will appreciate offsetting losses from the drop in the long position's value.Avid Bioservices Pair Trading
Avid Bioservices Pair Trading Analysis
The ability to find closely correlated positions to Avid Bioservices could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Avid Bioservices when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Avid Bioservices - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Avid Bioservices to buy it.
The correlation of Avid Bioservices is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Avid Bioservices moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Avid Bioservices moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Avid Bioservices can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Avid Bioservices position
In addition to having Avid Bioservices in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Corporate ETFs Thematic Idea Now
Corporate ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Corporate ETFs theme has 223 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Corporate ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities. To learn how to invest in Avid Stock, please use our How to Invest in Avid Bioservices guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
To fully project Avid Bioservices' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Avid Bioservices at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Avid Bioservices' income statement, its balance sheet, and the statement of cash flows.